Access the latest thinking from Europe’s leading cancer research organisation
The Institute of Cancer Research, London and the Science & Technology Facilities Council are pleased to invite you to a lunchtime briefing to explore the latest thinking from the ICR and opportunities to collaborate.
- When: Friday 7 June (12.30pm-3.30pm)
- Where: Science and Technology Facilities Council RAL at the Harwell Campus, Harwell, Oxford OX11 0QX - view map
The ICR is one of the world's most influential cancer research organisations. Our discoveries have led to many new treatments for people with cancer, and we consistently rank at or near the top of national and international rankings of academic innovation, impact on society and research excellence.
We are well known for establishing productive partnerships with industry, along with major research successes such as our discovery of the prostate cancer drug abiraterone. We have more than 100 current partnerships ranging from small, specialised biotech and medtech firms to big pharma.
About the event
Join ICR Director of Enterprise Dr Angela Kukula, Associate Director Business Development Dr Toby Richardson, ICR researchers and clinicians to learn more about our cutting-edge research, our culture of collaboration with industry, recent examples of our success and upcoming opportunities.
Hear about the experience and benefits of cross-organisational working to both academia and industry in talks from Nigel Brooks, Director at Cellcentric Ltd and Dr Barbara Camanzi STFC Healthcare Lead.
Most importantly, the afternoon will provide an opportunity to start conversations about how we can mutually share expertise to progress the discovery and development of potential cancer drugs and technologies to improve the lives of cancer patients and their families.
This event is free, but Harwell is a secure site and you must register to enable entry (please bring a form of photo ID with you).
For more information, please contact Andy Carr, Business Development Manager on [email protected] or 07718 490 707.